The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still lead ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about understanding Gleason Score and prostate cancer risk. A Gleason score is a ...
Overall survival and radiographic progression-free survival trends demonstrate treatment benefit of abiraterone acetate in prostate cancer. Overall survival and radiographic progression-free survival ...
Prostate cancer is an aggressive cancer that develops in the prostate gland, a small gland in the male reproductive system that produces fluid for semen. It is the most common cancer in men, after ...
Significant discrepancies exist between the GS determined by the prostate biopsy, and the GS based upon the pathologic specimen. It has been observed that the GS from needle biopsies underestimates ...
Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...
Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results